These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38018023)

  • 1. Clinical harm reduction in substance use: An ethics-oriented primer and critique for hospital-based providers.
    Kontos N; Rao V
    J Eval Clin Pract; 2024 Mar; 30(2):260-267. PubMed ID: 38018023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moral frameworks, ethical engagement and harm reduction: commentary on 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics' by C. L. Fry, C. Treloar & L. Maher.
    Keane H
    Drug Alcohol Rev; 2005 Nov; 24(6):551-2. PubMed ID: 16361212
    [No Abstract]   [Full Text] [Related]  

  • 4. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting moral values to enhance access to health care: harm reduction as a context for ethical nursing practice.
    Pauly BB
    Int J Drug Policy; 2008 Jun; 19(3):195-204. PubMed ID: 18467086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Hospital-Based Harm Reduction Care-Harnessing the Nursing Model.
    Goff A; Lujan-Bear S; Titus H; Englander H
    Subst Use Addctn J; 2024 Apr; 45(2):307-313. PubMed ID: 38258867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
    Forchuk C; Serrato J; Scott L
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm Reduction: A Misnomer.
    King NB
    Health Care Anal; 2020 Dec; 28(4):324-334. PubMed ID: 33151427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kantian Harm Reduction.
    Hoffman S
    Health Care Anal; 2020 Dec; 28(4):335-342. PubMed ID: 33064237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating conflicting value systems: a grounded theory of the process of public health equity work in the context of mental health promotion and prevention of harms of substance use.
    Marcellus L; Pauly B; Martin W; Revai T; Easton K; MacDonald M
    BMC Public Health; 2022 Feb; 22(1):210. PubMed ID: 35100999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To help and not to harm: ethical issues in the treatment of chronic pain in patients with substance use disorders.
    Geppert CM
    Adv Psychosom Med; 2004; 25():151-71. PubMed ID: 15248373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
    Vearrier L
    Dis Mon; 2019 May; 65(5):119-141. PubMed ID: 30600096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aristotle on drugs.
    Mercer T
    New Bioeth; 2013; 19(2):84-96. PubMed ID: 25109126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ethical Defensibility of Harm Reduction and Eating Disorders.
    Bianchi A; Stanley K; Sutandar K
    Am J Bioeth; 2021 Jul; 21(7):46-56. PubMed ID: 33370215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings.
    Lindenfeld Z; Hagan H; Chang JE
    J Gen Intern Med; 2023 Nov; 38(15):3273-3282. PubMed ID: 37227658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disgust or Dignity? The Moral Basis of Harm Reduction.
    Stoljar N
    Health Care Anal; 2020 Dec; 28(4):343-351. PubMed ID: 33098488
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.